Modern life means average family sizes are falling and, with less selection pressure on high fertility genes, more infertile genes mean more unsuccessful pregnancies. Enter the FelixTM device.
It’s true, there is a potential crisis in human fertility brewing. As societies become more affluent, they experience changes that have a dramatic impact on reproduction. As average family sizes fall, the selection pressure for high-fertility genes decreases and more infertility-linked genes pass onto next generations.
Add to that the many reasons for which male fertility rates are so low, including genetics and exposure to environmental toxins, and there’s a perfect storm of factors contriving to drive fertility rates down at unprecedented rates.
If society doesn’t realise the reality of this situation and react accordingly, an uncontrollable, irreversible decline in population numbers is likely. Each year the reproductive needs of some 120 million couples worldwide go unmet, and counting.
Enter Memphasys – Australian innovator in reproductive biotechnology with a motto of “better technology, more life” – and its groundbreaking Felix™ device.
The mission to deliver magnificent IVF
The sole reason that Memphasys exists is the development of solutions to meet market needs in human and animal fertility and reproduction, and the Felix™ is its first device to release into the commercial market – with commercial sale already happening in early adopting countries like India, Canada, and New Zealand, and clinical studies and preparations of filings for regulatory certifications underway in China and Australia.
In technical terms, Felix™ is an automated electrophoretic device which separates sperm from raw semen using a proprietary process which combines electrophoresis and size exclusion membranes. So sperm can be successfully harvested without risk from cellular contaminants such as leukocytes and precursor germ cells.
In simple terms, Felix™ is a clever container that performs a clever three-minute process on the semen sample, which makes it easier for the specialist to then separate the good sperm from the bad – an extraction process which is performed afterwards, using what looks like a special telescopic syringe with a glass tip which enables much faster and more accurate location and extraction.
What’s next in the IVF tech revolution?
Led by their Scientific Director, Professor John Aitken, a truly global leader in the field of reproductive biology, Memphasys is full steam ahead focussing on further innovation and development in the artificial reproduction and fertility market. The Professor and his team are a powerful, insightful force behind the development of this technology, driven by strong, personal determination to help empower healthy families around the world.
“The Felix™ is just the beginning of what I’m confident will be a brilliantly successful, long-term solution in the delivery of best practice reproductive health around the world,” Professor Aitken said.
“One look at the Memphasys product development pipeline over the next 5 years, which includes laboratory devices for use in artificial reproduction, diagnostic products for male and female fertility, and specialty media products for assisted reproduction processes, is clear proof that there are very exciting times ahead.”
Watch this space as Memphasys moves forward to further revolutionise the artificial reproduction and fertility market.